Investigating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Surface and Air Contamination in an Acute Healthcare Setting During the Peak of the Coronavirus Disease 2019 (COVID-19) Pandemic in London.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
05 10 2021
Historique:
received: 02 06 2020
accepted: 26 06 2020
pubmed: 8 7 2020
medline: 12 10 2021
entrez: 8 7 2020
Statut: ppublish

Résumé

We evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surface and air contamination during the coronavirus disease 2019 (COVID-19) pandemic in London. Prospective, cross-sectional, observational study in a multisite London hospital. Air and surface samples were collected from 7 clinical areas occupied by patients with COVID-19 and a public area of the hospital. Three or four 1.0-m3 air samples were collected in each area using an active air sampler. Surface samples were collected by swabbing items in the immediate vicinity of each air sample. SARS-CoV-2 was detected using reverse-transcription quantitative polymerase chain reaction (PCR) and viral culture; the limit of detection for culturing SARS-CoV-2 from surfaces was determined. Viral RNA was detected on 114 of 218 (52.3%) surfaces and in 14 of 31 (38.7%) air samples, but no virus was cultured. Viral RNA was more likely to be found in areas immediately occupied by COVID-19 patients than in other areas (67 of 105 [63.8%] vs 29 of 64 [45.3%]; odds ratio, 0.5; 95% confidence interval, 0.2-0.9; P = .025, χ2 test). The high PCR cycle threshold value for all samples (>30) indicated that the virus would not be culturable. Our findings of extensive viral RNA contamination of surfaces and air across a range of acute healthcare settings in the absence of cultured virus underlines the potential risk from environmental contamination in managing COVID-19 and the need for effective use of personal protective equipment, physical distancing, and hand/surface hygiene.

Sections du résumé

BACKGROUND
We evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surface and air contamination during the coronavirus disease 2019 (COVID-19) pandemic in London.
METHODS
Prospective, cross-sectional, observational study in a multisite London hospital. Air and surface samples were collected from 7 clinical areas occupied by patients with COVID-19 and a public area of the hospital. Three or four 1.0-m3 air samples were collected in each area using an active air sampler. Surface samples were collected by swabbing items in the immediate vicinity of each air sample. SARS-CoV-2 was detected using reverse-transcription quantitative polymerase chain reaction (PCR) and viral culture; the limit of detection for culturing SARS-CoV-2 from surfaces was determined.
RESULTS
Viral RNA was detected on 114 of 218 (52.3%) surfaces and in 14 of 31 (38.7%) air samples, but no virus was cultured. Viral RNA was more likely to be found in areas immediately occupied by COVID-19 patients than in other areas (67 of 105 [63.8%] vs 29 of 64 [45.3%]; odds ratio, 0.5; 95% confidence interval, 0.2-0.9; P = .025, χ2 test). The high PCR cycle threshold value for all samples (>30) indicated that the virus would not be culturable.
CONCLUSIONS
Our findings of extensive viral RNA contamination of surfaces and air across a range of acute healthcare settings in the absence of cultured virus underlines the potential risk from environmental contamination in managing COVID-19 and the need for effective use of personal protective equipment, physical distancing, and hand/surface hygiene.

Identifiants

pubmed: 32634826
pii: 5868534
doi: 10.1093/cid/ciaa905
pmc: PMC7454437
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1870-e1877

Subventions

Organisme : National Institute for Health Research

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Jie Zhou (J)

Department of Infectious Disease, Imperial College London, London, United Kingdom.

Jonathan A Otter (JA)

National Institute for Healthcare Research Health Protection Research Unit in Health-care Associated Infection and Antimicrobial resistance, Imperial College London & Public Health England, Hammersmith Hospital, London, United Kingdom.
Imperial College Healthcare National Health Service Trust, St. Mary's Hospital, London, United Kingdom.

James R Price (JR)

National Institute for Healthcare Research Health Protection Research Unit in Health-care Associated Infection and Antimicrobial resistance, Imperial College London & Public Health England, Hammersmith Hospital, London, United Kingdom.
Imperial College Healthcare National Health Service Trust, St. Mary's Hospital, London, United Kingdom.

Cristina Cimpeanu (C)

Imperial College Healthcare National Health Service Trust, St. Mary's Hospital, London, United Kingdom.

Danel Meno Garcia (D)

Imperial College Healthcare National Health Service Trust, St. Mary's Hospital, London, United Kingdom.

James Kinross (J)

Imperial College Healthcare National Health Service Trust, St. Mary's Hospital, London, United Kingdom.
Department of Surgery and Cancer, Imperial College London , London, United Kingdom.

Piers R Boshier (PR)

Imperial College Healthcare National Health Service Trust, St. Mary's Hospital, London, United Kingdom.
Department of Surgery and Cancer, Imperial College London , London, United Kingdom.

Sam Mason (S)

Imperial College Healthcare National Health Service Trust, St. Mary's Hospital, London, United Kingdom.
Department of Surgery and Cancer, Imperial College London , London, United Kingdom.

Frances Bolt (F)

National Institute for Healthcare Research Health Protection Research Unit in Health-care Associated Infection and Antimicrobial resistance, Imperial College London & Public Health England, Hammersmith Hospital, London, United Kingdom.
Imperial College Healthcare National Health Service Trust, St. Mary's Hospital, London, United Kingdom.

Alison H Holmes (AH)

National Institute for Healthcare Research Health Protection Research Unit in Health-care Associated Infection and Antimicrobial resistance, Imperial College London & Public Health England, Hammersmith Hospital, London, United Kingdom.
Imperial College Healthcare National Health Service Trust, St. Mary's Hospital, London, United Kingdom.

Wendy S Barclay (WS)

Department of Infectious Disease, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH